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Abstract
Angiotensin-(1-7) (Ang-(1-7)) increased osmotic water permeability
in the isolated toad skin, a tissue with functional properties similar to
those of the distal mammalian nephron. Concentrations of 0.1 to 10
µM were effective, with a peak at 20 min. This effect was similar in
magnitude to that of frog skin angiotensin II (Ang II) and oxytocin but
lower than that of human Ang II and arginine-vasotocin. The AT2
angiotensin receptor antagonist PD 123319 (1.0 µM) fully inhibited
the response to 0.1 µM Ang-(1-7) but had no effect on the response to
Ang II at the same concentration. The specific receptor antagonist of
Ang-(1-7), A-779, was ineffective in blocking the response to Ang-(1-
7) and to frog skin Ang II. The AT1 receptor subtype antagonist
losartan, which blocked the response to frog skin Ang II, was ineffec-
tive in blocking the response to Ang-(1-7). The present results support
the view of an antidiuretic action of Ang-(1-7) in the mammalian
nephron.
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Introduction
Angiotensin-(1-7) (Ang-(1-7)) is a bio-
logically active peptide of the renin-angio-
tensin system produced from angiotensin I
by an independent pathway of the angio-
tensin-converting enzyme with cellular func-
tions that differ from angiotensin II (Ang II)
(1,2). Several renal actions of Ang-(1-7) have
been reported, indicating that the peptide has
a role in hydromineral balance. In water-
loaded rats it produces marked antidiuresis
(3) by a direct effect on inner medullary
collecting ducts (4). This effect is not blocked
by the V2 receptor antagonist (4) but is
blocked by the specific antagonist A-779
(5,6) and losartan (7). Ang-(1-7) may play a
role during dehydration and hemorrhage in
rats (8). In the rat proximal straight tubules a
biphasic effect on fluid absorption blocked
by losartan has been reported (9), as well as
an inhibitory effect on sodium fluxes in proxi-
mal tubule cells (10). On the other hand,
diuretic and natriuretic effects in vivo (11)
and in the isolated rat kidney (12) have been
found which may involve PGI2 release (13).
Amphibian skin is a tissue with func-
tional properties similar to those of the distal
mammalian nephron (14). In isolated toad
skin Ang II increases osmotic water perme-
ability (Posm) (15) through a common re-
ceptor with antidiuretic hormone (16-19).
Confirming this effect, a primary antidiuretic
action of Ang II was demonstrated in the dog
kidney (20). In order to obtain further infor-
mation about the antidiuretic effect of Ang-
(1-7) we measured Posm in isolated toad
skin and compared its response to that ob-
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tained with other Ang II and neurohypophy-
seal peptides (oxytocin and arginine-vasoto-
cin).
Material and Methods
Toads (Bufo arenarum) hydrated over-
night were used. After pithing, the ventral
pelvic skin was dissected and divided into
two symmetrical parts which were mounted
(dermal surface outward) over the bottom of
plastic tubes (surface area 1.77 cm2) and
immersed in a bath of 10 ml of aerated
Ringer solution. The inner epidermal sur-
face was bathed with the same solution di-
luted 1/5 in distilled water and Posm was
measured gravimetrically by weighing the
tube on a scale (Mettler H10) to the nearest
0.1 mg. After an equilibration period of 1 h
in which the solutions were changed twice,
one or two control periods of 20 min were
allowed to elapse, followed by an experi-
mental one in which the Posm response to
the hormone added to the dermal bath was
measured. In some experiments, an antago-
nist was added to the paired half-skin 10 min
before the addition of the hormone (Ang II)
to both halves. In another experiment the
preparation was weighed during several pe-
riods of 20 min in order to determine the
time course of the response. Results are re-
ported as mg cm-2 h-1 and the hormonal
effect as the mean and standard error (SEM)
of the difference between the experimental
period and the previous control one. The
Ringer solution contained 90 mM NaCl, 2
mM KCl, 1 mM MgSO4, 1 mM CaCl2, 25
mM Tris-HCl buffer, and 5 mM glucose, pH
7.4, 220 mOsmol/kg H2O.
Drugs
Ang-(1-7) (Asp-Arg-Val-Tyr-Ile-His-Pro)
was synthesized by Dr. Clara Peæa, Departa-
mento de Química Biológica, Facultad de
Farmacia y Bioquímica, Universidad Nacio-
nal de Buenos Aires, Argentina, and also
obtained from Bachem (Torrance, CA, USA);
frog skin Ang II (Ala-Pro-Gly [Ile3,Val5]
angiotensin II), human Ang II (Asp-Arg-
Val-Tyr-Ile-His-Pro-Phe), oxytocin and ar-
ginine-vasotocin were purchased from Sigma
Chemical Co. (St. Louis, MO, USA); losar-
tan (DuP 753) was a gift from Dr. Ronald D.
Smith (DuPont Merck, Wilmington, DE,
USA); PD 123319 (P-186) was obtained
from Research Biochemicals Int. (Natick,
MA, USA); A-779 (Asp-Arg-Val-Tyr-Ile-
His-D-Ala) was a gift from Professor Robson
A.S. Santos (Belo Horizonte, MG, Brazil).
Statistical analysis
Results are reported as the mean – SEM
and the Student t-test for paired samples was
used for statistical analysis. When more than
two means were compared, one-way
ANOVA was performed, followed by the
Newman-Keuls test. The level of signifi-
cance was set at P<0.05.
Results
Ang-(1-7) significantly increased Posm
over basal flow at concentrations of 0.1 to 10
µM (Figure 1). The higher concentration (10
µM) elicited a lower response that was not
statistically different from 1 µM. Ang-(1-7)
obtained from two different sources did not
differ in the response elicited (data not
shown). Figure 2 comparatively shows the
response to different angiotensins and neu-
Figure 1 - Effect of different Ang-
(1-7) concentrations on osmotic
water permeability in isolated
toad skin. The number of experi-
ments is indicated in parenthe-
ses. N.S. Not significant; the P
values are given above the col-
umns. In this and following
graphs the mean effect and its
standard error (SEM) were ob-
tained from the difference be-
tween the experimental period
and the preceding control one
and the Student t-test for paired
samples was applied. One-way
ANOVA followed by the Duncan
test demonstrated that the
mean effects of different Ang-
(1-7) concentrations producing
significant increases in osmotic
water permeability did not differ
from one another.
O
sm
ot
ic
 w
at
er
 p
er
m
ea
bi
lit
y
(m
g 
cm
-2
 h
-1
)
40
30
20
10
0
-10
(10)
<0.01
(10)
<0.01
(10)
<0.02
(8)
N.S.
0.1 1 10
0.01
Ang-(1-7) (µM)
1101
Braz J Med Biol Res 33(9) 2000
Angiotensin-(1-7) and osmotic water permeability
rohypophyseal hormones (oxytocin and ar-
ginine-vasotocin). Arginine-vasotocin, the
antidiuretic neurohypophyseal hormone of
Amphibia, was by far more potent in in-
creasing Posm. The time course of the re-
sponse to Ang-(1-7) showed a peak at 20 min
after addition of the hormone to the dermal
bathing solution (Figure 3A,B). The response
of the skins varied widely. Figure 3B shows
the response of a highly reactive skin. A-779
(1 µM), a specific antagonist of Ang-(1-7),
had no effect on the response of toad skin to
0.1 µM Ang-(1-7) (Figure 4) and to 0.1 µM
frog skin Ang II (Figure 5). However, the
Posm response to Ang-(1-7) was com-
pletely blocked by the AT2 antagonist PD
123319 (Figure 6). The AT1 antagonist
losartan (Figure 7) was unable to block
the response to Ang-(1-7). The antago-
nists used (A-779, PD 123319 and losar-
tan) had no effect on basal osmotic water
permeability (data not shown).
Discussion
Ang-(1-7) significantly increased toad
skin Posm at concentrations of 0.1 to 10 µM
with a peak at 20 min similar to that observed
with Ang II (15). There was a wide variabil-
ity in the response between animals with
non-responsive skins and others showing a
clear response (Figure 3B). Human Ang II
was more potent than Ang-(1-7), whose ef-
fect was similar to that of frog skin Ang II, an
angiotensin peptide found in the skin of the
frog Crinia georgiana (21). Arginine-vaso-
tocin, the naturally neurohypophyseal pep-
tide existing in Amphibia, had the highest
effect. Doses of 10 µM Ang-(1-7) elicited
responses of lower magnitude, although with-
out being statistically significant. This may
be attributed to the release of inhibitory sub-
stances such as prostaglandins at these con-
centrations since PGE1 inhibited the effect
of Ang II on toad skin Posm (22). No effect
of Ang-(1-7) on Posm was found in the
isolated toad bladder (data not shown).
Figure 2 - Comparative effects of
different angiotensins (Ang) and
neurohypophyseal hormones on
osmotic water permeability in
isolated toad skin. Data are re-
ported as means ± SEM. The
numbers in parentheses indicate
the number of experiments and
the P values are given above the
columns. One-way ANOVA fol-
lowed by the Newman-Keuls test
demonstrated that the effect of
Ang-(1-7) was significantly lower
than that of human Ang II, oxyto-
cin and arginine-vasotocin but did
not differ from that of frog Ang II.
Oxyt, Oxytocin; AVT, arginine-va-
sotocin.
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Figure 3 - Time course of the response to Ang-(1-7). A, Mean ± SEM for 10 experiments; B
shows the response of a single reactive skin. The maximal responses occurred 20 min after
the addition of 1.0 µM Ang-(1-7) to the dermal surface of the skins.
Figure 4 - Lack of effect of the
specific Ang-(1-7) antagonist (A-
779) on osmotic water perme-
ability stimulated with Ang-(1-7).
Data are reported as means ±
SEM. One-way ANOVA followed
by the Newman-Keuls test
showed no significant differ-
ences (N.S.) between e1 and e2
or c1 and c2. In this and the fol-
lowing figures c1 and e1 are the
control and experimental periods
of one skin half and c2 and e2 the
control and experimental periods
of the other paired half.
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Figure 5 - Lack of effect of the
specific Ang-(1-7) antagonist (A-
779) on osmotic water perme-
ability stimulated with frog skin
Ang II. Data are reported as
means ± SEM. One-way ANOVA
followed by the Newman-Keuls
test showed no significant dif-
ferences (N.S.) between e1  and
e2 or c1 and c2.
The response of toad skin to Ang II is
mediated by an AT1 receptor subtype since
the effect of Ang II on Posm is blocked by
losartan but not by PD 123319 (17). The fact
that antidiuretic hormone antagonists blocked
the stimulating effect of Ang II on Posm (18)
and that losartan blocked the Posm response
to antidiuretic hormone in toad skin (19)
supports the view of a common receptor for
Ang II and antidiuretic hormone in toad skin.
In the present experiments, we unexpectedly
obtained a complete inhibition of the Posm
response to Ang-(1-7) by PD 123319 whereas
A-779, considered to be a specific antago-
nist of Ang-(1-7) (5,6), had no effect. Losar-
tan was also unable to block the response to
Ang-(1-7). A-779 completely blocked the
antidiuretic effect of Ang-(1-7) on water-
loaded rats, suggesting the existence of a
non-AT1 angiotensin receptor that is recog-
nized by losartan (7). Our results using PD
123319 showed that Ang-(1-7) increased
Posm mainly through an AT2 receptor which
in this case was not recognized by losartan,
an AT1 receptor subtype antagonist. Our
data concerning toad skin did not show a
specific receptor for Ang-(1-7), in contrast
to the ventrolateral medulla of rats (23,24),
porcine coronary artery rings (25) and bo-
vine aortic endothelial cells (26).
Blockade of the Ang-(1-7) receptor by
PD 123319 and losartan has been described
in studies on the release of [3H] norepineph-
rine from rat atria (27), suggesting that Ang-
(1-7) may act on receptor subtypes 1 and 2.
Also, in dog coronary arteries the release of
nitrites by Ang-(1-7) was reduced by losar-
tan and PD 123319 (28), as also was the
relaxing effect on preconstricted pig coro-
nary arteries in the presence of bradykinin
(29). In C6 glioma cells the effect of Ang-(1-
7) on prostaglandin synthesis was mediated
by subtype 1 angiotensin receptors (30).
Ang II may be converted to Ang-(1-7) by
carboxypeptidases and prolylcarboxypepti-
dase (31). If this were the case in our prepa-
ration, PD 123319, the specific antagonist of
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Figure 6 - Inhibition of the re-
sponse of toad skin to Ang-(1-7)
by the AT2 receptor antagonist
PD 123319. Data are reported as
means ± SEM. One-way ANOVA
followed by the Newman-Keuls
test showed a significant differ-
ence (*P<0.01) between the ex-
perimental periods e1 and e2.
There was no significant differ-
ence between c1 and c2.
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the AT2 receptor subtype which blocks the
effect of Ang-(1-7), would also block at least
partially the effect of Ang II on osmotic
water permeability in toad skin, but this inhi-
bition was not observed.
The results obtained here with toad skin,
a tissue with functional properties similar to
those of the distal mammalian nephron, sup-
port the antidiuretic effect of Ang-(1-7) ob-
served in the rat (3) and the increase in
hydraulic conductivity of mammalian inner
medullary collecting tubules (4). We dem-
onstrated for the first time the effect of an
angiotensin on Posm in isolated toad skin
mediated by an AT2 receptor subtype which
is not recognized by losartan.
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